2019
DOI: 10.1161/atvbaha.118.312201
|View full text |Cite
|
Sign up to set email alerts
|

Antiatherogenic Effect of Resveratrol Attributed to Decreased Expression of ICAM-1 (Intercellular Adhesion Molecule-1)

Abstract: Objective— Increasing evidence shows that resveratrol has antiatherogenic effects, but its underlying mechanisms are unknown. Thus, we evaluated the molecular mechanisms underlying the antiatherogenic effect of resveratrol. Approach and Results— Using the previously established mouse atherosclerosis model of partial ligation of the left carotid artery, we evaluated the role of resveratrol in antiatherosclerosis. We attempted to determine … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
28
1
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(31 citation statements)
references
References 51 publications
1
28
1
1
Order By: Relevance
“…There is also evidence that butyrate inhibits the acute lung injury in mice by regulating the NFκB signaling pathway [59]. Moreover, Nrf2-HO1 signaling is linked to ICAM-1 expression in a mouse atherosclerosis model [60], in THP-1 macrophages [61], and HaCaT cells [62]. However, in the present study, SnPP blocking HO1 activity could not reverse the inhibition of butyrate in ICAM-1 expression.…”
Section: Discussioncontrasting
confidence: 74%
“…There is also evidence that butyrate inhibits the acute lung injury in mice by regulating the NFκB signaling pathway [59]. Moreover, Nrf2-HO1 signaling is linked to ICAM-1 expression in a mouse atherosclerosis model [60], in THP-1 macrophages [61], and HaCaT cells [62]. However, in the present study, SnPP blocking HO1 activity could not reverse the inhibition of butyrate in ICAM-1 expression.…”
Section: Discussioncontrasting
confidence: 74%
“…In addition, resveratrol ameliorated atherosclerosis partially through restoring intracellular GSH via AMPK-α activation, resulting in inhibited monocyte differentiation and reduced pro-inflammatory cytokine production [59]. Moreover, resveratrol regulated the band 4.1, ezrin, radixin, and moesin (FERM)-kinase and Nrf2 interaction, leading to decreased expression of ICAM-1 and then the inhibition of monocyte adhesion [63]. Resveratrol also exhibited antithrombotic effects via decreasing the tissue factors like TNF-α, and such action could be facilitated by aortic endothelial cells that could deconjugate resveratrol metabolites to free resveratrol [64].…”
Section: Cardiovascular Diseasesmentioning
confidence: 99%
“…In vitro A549 cells 56.25, 112.5 µg/mL Triggering an immune response to protect against non-typeable Haemophilus influenzae without developing resistance [46] In vitro H1HeLa cells, Human nasal epithelia 0-300 µM Inhibiting human rhinoviruses-16 replication and normalized virus-induced IL-6, IL-8, and RANTES as well as the expression of ICAM-1 [47] In vitro Rhabdosarcoma cells 2.5-100 µg/mL Preventing EV71 replication, reducing the virus-induced elevated IL-6 and TNF-α secretion via suppressing IKK/NF-κB signaling pathway [48] In vivo Chickens 200, 400, 800 mg/kg Reducing immunocyte apoptosis in chickens receiving conventional vaccinations, and improving the growth of young chickens [49] In vivo Piglets 3, 10, 30 mg/kg/d Maintaining the immune function and attenuating diarrhea and inflammation [51] In vitro Atlantic salmon macrophages 10, 30, 50 µM Reducing bacterial and inflammatory biomarkers in LPS-challenged primary Atlantic salmon macrophages [52] In Improving central arterial wall stiffening based on its antioxidative and anti-inflammation [7] In vivo Rabbits 2.5 mg/kg Mitigating atrial fibrillation by upregulating PI3K/AKT/eNOS [8] In vitro Peripheral blood mononuclear cells 3-80 µM Blocking atherosclerotic plaque progression by acting against pro-atherogenic oxysterol signaling in M1 and M2 macrophages [57] In vivo Rats 50 mg/kg/day Preventing the activation of inflammasome via downregulating NF-κB p65 and p38 MAPK expression, and upregulating SIRT1 expression [62] In vivo Mice 20 mg/kg Regulated the FERM-kinase and Nrf2 interaction, decreasing the expression of ICAM-1, and inhibiting monocyte adhesion [63] In vivo Rats 1.24 µg/d Improving the cardiac and vascular autonomic function [65] In vitro Human RBCs 100 µM Protecting the erythrocytes via interacting with hemoglobin and reducing heme-iron oxidation [66] Cancers In vitro LNCaP cells 5, 10, 20, 50 µM Inducing the expression of COX-2, promoting ERK1/2 activation, and facilitating p53-dependent anti-proliferation gene expression [14] In vitro; In vivo tBregs; Mice 12.5 µM; 20, 50, 500 µg/mouse Preventing breast cancer metastasis by promoting antitumor immune responses via blunting STAT3, leading to inhibited generation and function of tBregs as well as decreased production of TGF-β [67] In In vitro A2780, OVCAR-3, SKOV-3 cells 10, 50, 100 µM…”
Section: Immunomodulating Effectsmentioning
confidence: 99%
“…Rather than regulated serum lipids, RES attenuated Trimethylamine-N-Oxide (TMAO)-induced AS in ApoE -/mice [33], ameliorated HFD induced AS in LDLR -/mice [34], countered systemic lupus erythematosus-associated AS [35] and alleviated AS in atherosclerotic mice whose left carotid artery was partial ligated [36]. Our result is consistent with previous studies that RES possess beneficial effects on AS and the influences of RES on AS induced by HFD and LPS was firstly observed in our research.…”
Section: Discussionmentioning
confidence: 99%